Rare Findings in Cleidocranial Dysplasia Caused by RUNX Mutation

Abstract

Background Cleidocranial dysplasia (CCD, #MIM119600) is an autosomal-dominant skeletal dysplasia characterized by delayed closure of the cranial sutures, aplasia, or hypoplasia of the clavicles and dental abnormalities. These findings were accompanied by mobile and drooping shoulders, frontal and parietal bossing, hypertelorism, brachycephaly, short stature, supernumerary, and late erupting teeth. Radiographic studies can reveal involvement of multiple bones including skull, chest, pelvis, and limbs. CCD can be diagnosed with clinical and radiological evaluation and validated by molecular studies. Heterozygous loss of function RUNX2 gene, which plays an important role in osteogenesis and differentiation of precursor cells, causes CCD phenotype.

Methods In this article, we reported five cases from three unrelated families with CCD phenotype. All exons and exonic–intronic boundary regions of RUNX2 gene from five patients were analyzed by polymerase chain reaction amplification and direct Sanger-sequencing.

Results Our patients had classical CCD phenotype and we detected three different previously described mutations including c.1171C > T, IVS4 + 4delAAGT and c.676G > A. However, nail dysplasia has never been associated with these mutations. Our patients had varying degrees of nail dysplasia. Two of three mutations are related with Runt DNA-binding domain of RUNX2 protein in Wnt signaling and c.1171C > T had effect on proline/serine/threonine-rich (PST) domain. Recently, Wnt signaling pathway was presented as a key regulator of digit and nail differentiation. Our data suggest that RUNX2 gene may have an essential role on embryogenesis of nails, probably by protecting their integrity.

Keywords

cleidocranial dysplasia - RUNX mutation - Sanger sequencing - rare findings

Ethical Approval

This research has been approved by the IRB of the authors' affiliated institutions and conducted in accordance with the Declaration of Helsinki.

Note

Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

Data available on request due to restrictions privacy or ethical. The data presented in this study are available on request from the corresponding author.

Publikationsverlauf

Eingereicht: 05. Juli 2021

Angenommen: 31. August 2021

Artikel online veröffentlicht:
22. Oktober 2021

• References

• 1 Machol K, Mendoza-Londono R, Lee B. Cleidocranial dysplasia spectrum disorder. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K. et al., editors GeneReviews [Internet]. Seattle: University of Washington, Seattle; 1993-2020
• 2 Stevenson DA, Carey JC, Byrne JLB, Srisukhumbowornchai S, Feldkamp ML. Analysis of skeletal dysplasias in the Utah population. Am J Med Genet A 2012; 158A [phone]
• 3 Romeo U, Galluccio G, Palaia G. et al. Cleidocranial dysplasia: maxillary alterations on the transverse plane. Presence of crown-radicular anomalies and multidisciplinary approach of a clinical case. Oral Health Dent Manag 2014; 13 (02) 529-535
• 4 Nagarathna C, Shakuntala BS, Mathew S, Krishnamurthy NH, Yumkham R. Cleidocranial dysplasia presenting with retained deciduous teeth in a 15-year-old girl: a case report. J Med Case Reports 2012; 6: 25
• 5 Golan I, Baumert U, Hrala BP, Müssig D. Dentomaxillofacial variability of cleidocranial dysplasia: clinicoradiological presentation and systematic review. Dentomaxillofac Radiol 2003; 32 (06) 347-354
• 6 Cohen Jr MM. Biology of RUNX2 and cleidocranial dysplasia. J Craniofac Surg 2013; 24 (01) 130-133
• 7 Rudnicki MA, Williams BO. Wnt signaling in bone and muscle. Bone 2015; 80: 60-66
• 8 Gaur T, Lengner CJ, Hovhannisyan H. et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005; 280 (39) 33132-33140
• 9 Takeo M, Chou WC, Sun Q. et al. Wnt activation in nail epithelium couples nail growth to digit regeneration. Nature 2013; 499 (7457): 228-232
• 10 Cunningham ML, Seto ML, Hing AV, Bull MJ, Hopkin RJ, Leppig KA. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations. Birth Defects Res A Clin Mol Teratol 2006; 76 (02) 78-85
• 11 Visosky AM, Johnson J, Bingea B, Gurney T, Lalwani AK. Otolaryngological manifestations of cleidocranial dysplasia, concentrating on audiological findings. Laryngoscope 2003; 113 (09) 1508-1514
• 12 Guo YW, Chiu CY, Liu CL, Jap TS, Lin LY. Novel mutation of RUNX2 gene in a patient with cleidocranial dysplasia. Int J Clin Exp Pathol 2015; 8 (01) 1057-1062
• 13 Otto F, Kanegane H, Mundlos S. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat 2002; 19 (03) 209-216
• 14 Ott CE, Leschik G, Trotier F. et al. Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum Mutat 2010; 31 (08) E1587-E1593
• 15 Hansen L, Riis AK, Silahtaroglu A. et al. RUNX2 analysis of Danish cleidocranial dysplasia families. Clin Genet 2011; 79 (03) 254-263
• 16 Baumert U, Golan I, Redlich M, Aknin JJ, Muessig D. Cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group. Am J Med Genet A 2005; 139A (02) 78-85
• 17 Tang S, Xu Q, Xu X. et al. A novel RUNX2 missense mutation predicted to disrupt DNA binding causes cleidocranial dysplasia in a large Chinese family with hyperplastic nails. BMC Med Genet 2007; 8: 82